Tissue therapies posts small loss

By Renate Krelle
Thursday, 10 February, 2005

Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.

At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.

It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.

Placentas affected by pre-eclampsia show several signs of accelerated aging, including increased...

Offering state-subsidised access to researchers and biotech startups, the facility aims to enable...

Adding a personalised, mRNA-based cancer vaccine to standard immunotherapy after surgery for...

Content from other channels on our network

APPEX 2027 to spotlight packaging trends

AirTrunk and European Energy to build renewables in the Hunter

Australian Vanadium secures funding for electrolyte manufacturing

SPEE3D launches Darwin manufacturing facility

Delorean finalises funding for Sydney renewable gas project

Closing the sensory gap with no- and low-alcohol wine

Balancing Food Safety, Traceability and Growth in a Changing Manufacturing Environment

Electrical technique for dehydrating milk, without heat

Ballarat food manufacturer plans to expand with new facility

$70m facility to strengthen local packaging production

Oral care and the prevention of hospital-acquired pneumonia: new evidence for infection prevention and control practice

"Distressing" accounts of hospital violence — NSW to recruit 129 security staff

"Pointless scans" to diagnose knee osteoarthritis may trigger inappropriate care, the Commission warns

Opinion: Why the role of continuous glucose monitors is expanding rapidly in primary health care

What the RACGP 6th edition means for cleaning in general practice